...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Updates
Reply New Message
Back To Forum List View
Zenith Updates
1
Toinv
Jan 29, 2016 10:52AM
Icon president Re: Zenith Updates
6
BearDownAZ
Jan 29, 2016 12:50PM
Re: Zenith Updates
5
KayakerBC
Jan 30, 2016 10:49AM
Re: Zenith Updates
5
KayakerBC
Jan 30, 2016 11:14AM
Re: Zenith Updates
5
chicagoest
Jan 30, 2016 01:05PM
Icon president Re: Zenith Updates
7
BearDownAZ
Feb 02, 2016 02:53PM
Re: Zenith Updates
3
masila
Feb 02, 2016 07:02PM
Re: Zenith Updates
3
chicagoest
Feb 02, 2016 07:40PM
Icon president Re: Zenith Updates
6
BearDownAZ
Feb 02, 2016 10:41PM
Re: Zenith Updates
4
chicagoest
Feb 03, 2016 08:41AM
Re: Zenith Updates

Hartland
Feb 03, 2016 09:08AM

Hartland

I am not quite sure where the trial commencement stands. The Zenith website states -

Phase 1 is expected to commence in the first half of 2016

Sarah's comment to BDAZ implies that the trial has not yet started but is the top priority

3 Recommendations
Icon president Re: Zenith Updates
2
BearDownAZ
Feb 03, 2016 12:21PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply